Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Some optimal and non-optimal two-stage designs using an alpha-spending function

H I Patel1

  • 1Berlex Laboratories, Inc., Wayne, NJ 07470, USA.

Statistics in Medicine
|August 30, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genitourinary injuries in the newborn.

Journal of pediatric surgery·2001
Same author

Sample size for comparing linear growth curves.

Journal of biopharmaceutical statistics·1999
Same author

Surgery for Crohn's disease in infants and children.

Journal of pediatric surgery·1997
Same author

Analysis of a within-subject design with covariates.

Journal of biopharmaceutical statistics·1997
Same author

Analysis of paired ordered categorical data in a factorial design.

Journal of biopharmaceutical statistics·1996
Same author

Multistage test procedure for testing Blackwelder's hypothesis of equivalence.

Journal of biopharmaceutical statistics·1994
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

Optimizing group sequential clinical trials involves determining interim analysis timing. This study minimizes average trial size for a specified power using Lan-DeMets alpha-spending functions, enhancing pharmaceutical research efficiency.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmaceutical Research

Background:

  • Determining optimal interim analysis timing is a critical challenge in group sequential clinical trials.
  • Efficient clinical trial design requires balancing sample size, power, and trial duration.

Purpose of the Study:

  • To optimize sample size calculations for two-stage group sequential trials.
  • To minimize average trial size while maintaining specified statistical power.
  • To explore alternative optimization objectives, including maximizing power for a fixed average size.

Main Methods:

  • Utilizing Lan-DeMets alpha-spending functions for interim analysis monitoring.
  • Computing optimal sample sizes (n for interim, N for final analysis) per treatment group.

Related Experiment Videos

  • Investigating scenarios for minimizing average trial size and maximizing overall power.

    • Main Results:

    • The study provides a framework for optimizing sample sizes in two-stage trials.
    • Demonstrates the application of Lan-DeMets functions for flexible interim analysis planning.
    • Addresses the trade-offs between sample size, power, and trial duration.

    Conclusions:

    • Optimal interim analysis timing can significantly reduce average clinical trial size.
    • The Lan-DeMets alpha-spending function offers flexibility in group sequential trial design.
    • Methodology aids pharmaceutical researchers in efficient clinical trial planning and resource allocation.